| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 26A021 | MAT2A-IN-22 | 2925330-18-1 | ≧98.0% | ![]() |
| MAT2A-IN-22 (Compound 29-1) 是一种可透过血脑屏障的和口服有效的 MAT2A | ||||
| 25210 | MAT2A-IN-23 | 2925324-58-7 | ≧98.0% | ![]() |
| MAT2A-IN-23 是一种潜在的MTA2A抑制剂。 | ||||
| 25208 | MK256 | 2271348-04-8 | ≧98.0% | ![]() |
| MK256是一种新型CDK8抑制剂,通过下调STAT通路在急性髓系白血病( | ||||
| 25206 | MA242 TFA | 1049704-18-8 | ≧98.0% | ![]() |
| MA242是一种MDM2和NFAT1双重抑制剂,可诱导MDM2自泛素化及降解,并抑 | ||||
| 25204 | MAT2A inhibitor 5 | 2957874-18-7 | ≧98.0% | ![]() |
| MAT2A抑制剂5具有抑制MAT2A的高效力和对MTAP缺失的癌症细胞系的显著 | ||||
| 186264 | MTX115325 | 2750895-97-5 | ≧98.0% | ![]() |
| MTX115325是一种强效、选择性、脑渗透性USP30抑制剂,具有良好的类 | ||||
| 25147 | GSK4362676 ( MAT2A-IN-9 ) | 2439277-80-0 | ≧98.0% | ![]() |
| MAT2A-IN-9 ( GSK4362676 )是一种2-氧代喹唑啉衍生物,是一种强效的MAT2 | ||||
| 25143 | MEN-1703 | 2769008-22-0 | 98% Min. | ![]() |
| 25130 | MSC2360844 hemifumarate | 1621688-31-0 | 98% Min. | ![]() |
| 25126 | Maralixibat Chloride | 228113-66-4 | 98% Min. | ![]() |
| Maralixibat (also known as SHP625, LUM001, and lopixibat) is an ileal bile acid trans | ||||
| 25097 | 4-甲基-1H-吲哚-2-腈 | 1541530-91-9 | ≧97.0% | ![]() |
| 25090 | Miricorilant | 1400902-13-7 | 98% Min. | ![]() |
| Miricorilant is discontinued. | ||||
| 25073 | MGD-28 | 2991818-13-2 | 98% Min. | ![]() |
| MGD-28 is a potent molecular glue degrader that demonstrates significant in vitro eff | ||||
| 25057 | MFI8 | 694488-83-0 | 98% Min. | ![]() |
| MFI8 is a Mitochondrial Fusion Inhibitor | ||||
| 25039 | MS6105 | 2891709-58-1 | 98% Min. | ![]() |
| 25017 | M3554 | 2763252-25-9 | ≧95.0% | ![]() |
| M3554,一种新型抗GD2抗体药物偶联物。 | ||||
| 25016 | MD-43 | ≧98.0% | ![]() | |
| MD-43是MCT4的强效选择性降解剂。 | ||||
| 24158 | ML-202 | 1221186-52-2 | 98% Min. | ![]() |
| ML-202 is an activator of pyruvate kinase M2 (PKM2). | ||||
| 24151 | ML353 | 2990506-75-5 | 98% Min. | ![]() |
| ML353 is a selective ligand of mGlu5 silent allosteric modulator (SAM). | ||||
| 24150 | MIF098 | 1208448-95-6 | 98% Min. | ![]() |
| MIF098 is a macrophage migration inhibitory factor (MIF) antagonist. | ||||
| 24124 | Mevrometostatum | 1844849-10-0 | 98% Min. | ![]() |
| Mevrometostatum is an enhancer of zeste homolog 2 (EZH2) inhibitor. | ||||
| 24044 | 3-甲磺酰基丙腈 | 54863-37-5 | 98% Min. | ![]() |
| Dapansutrile is a potent, orally active and selectiveNLRP3inflammasome inhibitor. Dap | ||||
| 20675 | Mavoglurant | 543906-09-8 | 98% Min. | ![]() |
| 262401 | MRTX1719 | 2630904-45-7 | ≧96.0% | |
| MRTX1719 is a potent and selective binder to the PRMT5•MTA complex and selectively | ||||
| 20615 | Mavodelpar | 942594-93-6 | 98% Min. | ![]() |
| Mavodelpar is a peroxisome proliferator activated receptor (PPAR) delta agonist. | ||||
| 20611 | MRTX849 | 2326521-71-3 | 98% Min. | ![]() |
| Adagrasib, also known as MRTX849, is a potent, highly selective, oral available KRAS | ||||
| 20592 | Migoprotafib | 2377352-49-1 | 98% Min. | ![]() |
| Migoprotafib, also known as GDC-1971 and RLY-1971, is a SHP2 allosteric inhibitor. GD | ||||
| 20572 | Mtb-IN-2 | 2861190-30-7 | 98% Min. | ![]() |
| Mtb-IN-2 (compound 10c) is an antimicrobial agent against Mycobacterium tuberculosis | ||||
| 20542 | MBX-8025 lysine anhydrous | 928821-41-4 | 98% Min. | ![]() |
| MBX-8025 lysine anhydrous is a selective PPAR-delta agonist. | ||||
| 20529 | Milademetan free base | 1398568-47-2 | 98% Min. | ![]() |
| Milademetan, also known as DS-3032b or DS-3032, is a potent and selective MDM2 inhibi | ||||
